Post by Framatome

281,927 followers

āœ… š—”š—„š—š š—£š—®š—¹š—¹š—®š˜€ š˜€š—²š—¹š—²š—°š˜š˜€ š—™š—æš—®š—ŗš—®š˜š—¼š—ŗš—² š˜š—¼ š—½š—æš—¼š˜ƒš—¶š—±š—² š—œ&š—– š˜€š—®š—³š—²š˜š˜† š˜€š˜†š˜€š˜š—²š—ŗš˜€ š—³š—¼š—æ š—¶š˜š˜€ š—»š—²š˜„ š—£š—”š—Ÿš—Ÿš—”š—¦ š—»š˜‚š—°š—¹š—²š—®š—æ š—æš—²š˜€š—²š—®š—æš—°š—µ š—»š˜‚š—°š—¹š—²š—®š—æ š—æš—²š—®š—°š˜š—¼š—æ Currently under construction in Petten (NL), the new PALLAS nuclear research reactor will play a key role in medical isotope production. šŸ”“ To ensure the highest levels of safety, reliability and cybersecurity, Framatome will deliver the First Reactor Protection System (FRPS) based on its TXS Core digital I&C solution, a proven technology for nuclear safety systems. šŸ”µ This agreement marks an important milestone for the project and contributes to securing the long-term global supply of life-saving medical isotopes, while supporting advances in nuclear research. ā„¹ļø Signatories from left to right : Jelmer Offerein, NRG PALLAS, Maik Smit , NGR PALLAS , Laurent THIEFFRY, Framatome, Tanja P., Framatome More information āž”ļø https://lnkd.in/dnGHtfvh

Post contentPost content